131 related articles for article (PubMed ID: 32303129)
1. Association of NAD (P) H Quinine Oxidoreductase 1 rs1800566 Polymorphism with Bladder and Prostate Cancers - a Systematic Review and Meta-Analysis.
Abedinzadeh M; Moghimi M; Dastgheib SA; Maleki H; Salehi E; Zare M; Jarahzadeh HM; Neamatzadeh H
Klin Onkol; 2020; 33(2):92-100. PubMed ID: 32303129
[TBL] [Abstract][Full Text] [Related]
2. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
Zhang H; Wen X; Lu X; Zhang H
Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
[TBL] [Abstract][Full Text] [Related]
3. The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects.
Guo ZJ; Feng CL
Asian Pac J Cancer Prev; 2012; 13(12):6343-8. PubMed ID: 23464456
[TBL] [Abstract][Full Text] [Related]
4. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".
Yadav U; Kumar P; Rai V
Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study.
Yang S; Zhao J; Li L
Medicine (Baltimore); 2020 May; 99(20):e19941. PubMed ID: 32443295
[TBL] [Abstract][Full Text] [Related]
6. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
Gong M; Yi Q; Wang W
Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
[TBL] [Abstract][Full Text] [Related]
7. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.
Ding R; Lin S; Chen D
Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148
[TBL] [Abstract][Full Text] [Related]
8. Association between NQO1 C609T polymorphism and prostate cancer risk.
Sun Z; Cui Y; Pei J; Fan Z
Tumour Biol; 2014 Aug; 35(8):7993-8. PubMed ID: 24838947
[TBL] [Abstract][Full Text] [Related]
9. The association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta-analysis of 22 studies.
Zhang Y; Yang D; Zhu JH; Chen MB; Shen WX; He J
Cancer Invest; 2015 Mar; 33(2):39-40. PubMed ID: 25608636
[TBL] [Abstract][Full Text] [Related]
10. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
11. Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.
Huang ZM; Chen HA; Chiang YT; Shen CH; Tung MC; Juang GD
J Chin Med Assoc; 2014 Feb; 77(2):83-8. PubMed ID: 24315573
[TBL] [Abstract][Full Text] [Related]
12. The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis.
Lajin B; Alachkar A
Br J Cancer; 2013 Sep; 109(5):1325-37. PubMed ID: 23860519
[TBL] [Abstract][Full Text] [Related]
13. NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.
Yin J; Wang L; Wang X; Zheng L; Shi Y; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
Scand J Gastroenterol; 2014 Mar; 49(3):317-22. PubMed ID: 24354914
[TBL] [Abstract][Full Text] [Related]
14. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
[TBL] [Abstract][Full Text] [Related]
15. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.
Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R
Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831
[TBL] [Abstract][Full Text] [Related]
16. A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis.
Yu H; Liu H; Wang LE; Wei Q
PLoS One; 2012; 7(1):e30566. PubMed ID: 22272361
[TBL] [Abstract][Full Text] [Related]
17. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis.
Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F
Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139
[TBL] [Abstract][Full Text] [Related]
18. Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence.
Liu H; Zhang W; Deng XD; Ma Y; Liu Y
Mol Genet Genomic Med; 2021 Oct; 9(10):e1789. PubMed ID: 34467676
[TBL] [Abstract][Full Text] [Related]
19. Research on the effects of rs1800566 C/T polymorphism of NAD(P)H quinone oxidoreductase 1 gene on cancer risk involves analysis of 43,736 cancer cases and 56,173 controls.
Zhou H; Wan H; Zhu L; Mi Y
Front Oncol; 2022; 12():980897. PubMed ID: 36338728
[TBL] [Abstract][Full Text] [Related]
20. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.
Chen J; Lin Y; Zhang R; Huang ZJ; Pan XG
Arch Med Res; 2012 Jan; 43(1):58-66. PubMed ID: 22306249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]